Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 10:8:224.
doi: 10.3389/fimmu.2017.00224. eCollection 2017.

Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates

Affiliations
Review

Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates

Luiz R Travassos et al. Front Immunol. .

Abstract

Dimorphic fungi are agents of systemic mycoses associated with significant morbidity and frequent lethality in the Americas. Among the pathogenic species are Paracoccidioides brasiliensis and Paracoccidioides lutzii, which predominate in South America; Histoplasma capsulatum, Coccidioides posadasii, and Coccidioides immitis, and the Sporothrix spp. complex are other important pathogens. Associated with dimorphic fungi other important infections are caused by yeast such as Candida spp. and Cryptococcus spp. or mold such as Aspergillus spp., which are also fungal agents of deadly infections. Nowadays, the actual tendency of therapy is the development of a pan-fungal vaccine. This is, however, not easy because of the complexity of eukaryotic cells and the particularities of different species and isolates. Albeit there are several experimental vaccines being studied, we will focus mainly on peptide vaccines or epitopes of T-cell receptors inducing protective fungal responses. These peptides can be carried by antibody inducing β-(1,3)-glucan oligo or polysaccharides, or be mixed with them for administration. The present review discusses the efficacy of linear peptide epitopes in the context of antifungal immunization and vaccine proposition.

Keywords: Paracoccidioides; antibody; fungi; peptide; vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lung tissue from BALB/c mice infected with Paracoccidioides brasiliensis vaccinated or not with peptide P10. (A) Lung tissue of control only infected mice. Bar, 400 μm. (B) Lung tissue of mice infected with Paracoccidioides brasiliensis and vaccinated with P10 in presence of cationic lipid. Bar, 400 μm. (C) Highly magnified lung tissue of control, only infected mice. Bar, 50 μm. (D) Lung tissue of mice infected with Paracoccidioides brasiliensis and vaccinated with P10 in presence of cationic lipid. Bar, 400 μm. Slides were stained with Grocott-Gomori methenamine silver. Pictures were taken using EVOS fluorescence microscopy (AMG). The Animal Care and Use Committee of the University of São Paulo approved all in vivo testing.

Similar articles

Cited by

References

    1. Souza ACO, Taborda CP. Epidemiology of dimorphic fungi. In: Reference Module in Life Sciences. Elsevier: (2017). 10.1016/B978-0-12-809633-8.12056-4 - DOI
    1. Coelho C, Casadevall A. Cryptococcal therapies and drug targets: the old, the new and the promising. Cell Microbiol (2016) 18:792–9. 10.1111/cmi.12590 - DOI - PMC - PubMed
    1. Cassone A, Cauda R. Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders. AIDS (2012) 26:1457–72. 10.1097/QAD.0b013e3283536ba8 - DOI - PubMed
    1. Al-Bader N, Sheppard DC. Aspergillosis and stem cell transplantation: an overview of experimental pathogenesis studies. Virulence (2016) 7:950–66. 10.1080/21505594.2016.1231278 - DOI - PMC - PubMed
    1. Datta K, Hamad M. Immunotherapy of fungal infections. Immunol Invest (2015) 44:738–76. 10.3109/08820139.2015.1093913 - DOI - PubMed